Alaunos Therapeutics Inc (NASDAQ:TCRT) has a beta value of -0.74 and has seen 5.34 million shares traded in the last trading session. The company, currently valued at $3.45M, closed the last trade at $2.16 per share which meant it gained $0.69 on the day or 46.94% during that session. The TCRT stock price is -775.0% off its 52-week high price of $18.90 and 39.35% above the 52-week low of $1.31. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.55 million shares traded. The 3-month trading volume is 13.52K shares.
The consensus among analysts is that Alaunos Therapeutics Inc (TCRT) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Alaunos Therapeutics Inc (NASDAQ:TCRT) trade information
Sporting 46.94% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TCRT stock price touched $2.16 or saw a rise of 21.45%. Year-to-date, Alaunos Therapeutics Inc shares have moved 13.39%, while the 5-day performance has seen it change 34.10%. Over the past 30 days, the shares of Alaunos Therapeutics Inc (NASDAQ:TCRT) have changed 37.58%. Short interest in the company has seen 51732.0 shares shorted with days to cover at 5.18.
Alaunos Therapeutics Inc (TCRT) estimates and forecasts
The company’s shares have lost -30.55% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 21.41% over the past 5 years.
TCRT Dividends
Alaunos Therapeutics Inc is expected to release its next earnings report on 2024-Mar-31 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Alaunos Therapeutics Inc (NASDAQ:TCRT)’s Major holders
Insiders own 14.11% of the company shares, while shares held by institutions stand at 4.51% with a share float percentage of 5.25%. Investors are also buoyed by the number of investors in a company, with Alaunos Therapeutics Inc having a total of 33.0 institutions that hold shares in the company. The top two institutional holders are MSD PARTNERS, L.P. with over 1.01 million shares worth more than $0.71 million. As of 2024-06-30, MSD PARTNERS, L.P. held 6.3082% of shares outstanding.
The other major institutional holder is MAGNOLIA CAPITAL ADVISORS LLC, with the holding of over 20607.0 shares as of 2024-06-30. The firm’s total holdings are worth over $14404.0 and represent 0.1287% of shares outstanding.
